Creative Details

Quality Score: 8/10

The advertisement promotes "Sylnd" drospirenone tablets, highlighting that they are now covered by most public and private insurance plans and encourages potential users to discuss the option with their doctor.

Creative Information

CID:3ee47977-b545-49c2-b971-32f683dad6b5
CRID:25_ny02oo6q
Domain:slynd.ca
Seat:TTD
Size:320x50
Bid:$0.13
Timestamp:10/31/2025, 6:07:27 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess12/10/2025, 1:47:10 AM12.04s
    adomain_analysissuccess12/10/2025, 5:34:58 AM7.96s
    adomain_capturesuccess12/10/2025, 5:34:48 AM0.15s
    ad_rendersuccess12/10/2025, 1:22:34 AM0.01s
    brand_mappingsuccess11/28/2025, 5:38:12 PM0.12s

    Analysis Results

    Ad Format: banner

    Brands: Slynd

    Sensitive:Pharmaceutical Products
    Size:320x50
    Data Transferred:35.96 KB
    Render Time:6.70 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Personal Finance (IAB13)
    Creative Inferred IAB Ad Products:
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    • Sexual Health (1519)
    • Doctor Perscribed Medicines (1521)
    Landing Page:
    https://slynd.ca/en?utm_medium=banners&utm_source=...
    Domain:slynd.ca
    Brand:
    Slynd
    Total Ad Size:55.05 KB
    Requests Made:
    URLSize (KB)
    https://choices.truste.com/ca?pid=tradedesk01&aid=tradedesk01&cid=qj5hz22_5d11yuc_ny02oo6q&c=tradedesk01cont1&js=pmw0&w=320&h=50&sid=0&dsarequired=&dsabehalf=&dsapaid=&dsaparams=21.11
    https://choices.trustarc.com/get?name=pmw2.js19.05
    https://ad.adsrvr.org/aeeepmp/e13r4cl/ny02oo6q_320x50.gif?cb=69897014.07
    https://wa2-bid.adsrvr.org/bid/feedback/kargo?t=1&iid=e9a632b4-94b6-4e21-9104-0c4d8b22f3c4&crid=ny02oo6q&wp=0.1261102&aid=496668ba-b8c2-4c3f-b09c-c9375a1225c6&wpc=USD&sfe=1b385e96&puid=1bdc792f-9b36-4676-b1dd-1e3b2c2394ba&bdc=137&tdid=3acea00f-f78d-4f94-80dc-d993f235617b&uidd=H9yAuDUENE4MQ8p7AFsW9-6xI6OfMO7mtQkw9qSbQ3s3LhPf&pid=aeeepmp&ag=5d11yuc&adv=e13r4cl&sig=1SkPuZqyDXarL3dlbIHHT-N6PMbI49YsteqVJ1PigPF4.&bp=0.209899235998639&cf=9590720&fq=0&td_s=reallittlemeals.com&rcats=2ic,7gr,hhr,hmy,26o,zm4,5dm&mste=&mfld=3&mssi=&mfsi=&uhow=56&agsa=&rgz=V9Y&svbttd=1&dt=Mobile&osf=Android&os=Android100&br=Chrome&rlangs=en&mlang=&svpid=8482&did=&rcxt=MobileOptimizedWeb&lat=49.260000&lon=-124.810000&tmpc=5.470000000000027&daid=&vp=0&osi=&osv=&bffi=41&mk=Android&mdl=Generic%20Android%20Mobile&testid=%20TTDContextualTest%20iavc1%20&npt=2&cc=1~KLUv_WNa1XJFfgB1CgDjk0zeQB5vAM8buOsZsOsZsP4K3LFoCCBiCeR5Anm4WoVKIehS74qAMVs2_DRiZFeNcUYuSOALa0UKAStrBQsBKH4AKhcDduYAO-YA69oAKK6Qdf8AOlcI3OP6BgxBIAAvhVhPQBsvAIoPAIkNkAelPvW4FwcGuPoAWOqbaZvZzTqsqy4qi8wuryVeomuDE7-pdptem3WVMAuTEGCIKALCniFAfFzglia_BYndumsBmdra6S0o7VYSditIbytHTwsVqwVKQBAtRAKCaOVpmdHtJzWFT2sHB5kDbZR_WYJaq56sIC2ZLVioWitYsFC1Vj1YqHpC1v1YijwWFI-VxLt5gMAcPWGW-3-qWB8k1nfnM9P-PM_hxnVbCf3aGnJlYAXVGTUkYrb1lRRAEYGJmkxcYDRYBuAG_NCW_0Nn6Nr__ZrIlIHFsTQ4Yf28VB8C&dur=1~KLUv_WMFoCgk1gHlBwDTSSURRBBBBD4RXEAGSwRUsaneyskkTLwF7HzxajgkbcRfWjzXSEs-Fwjh1XA5Gs_gKZZBb2oiwCQxPAfAXl3Jc5FCWlpy0pKzZYsPAqrYlqTyUpJ_ZRrVdnhNOBpeE84GZ3nqwtQFKaoLz5Dmd4r3gqUfMWmJqlFehKzUKkB9Cs-SFUqtcNkXSErrAhwCqtgsXZLVGmXaUyL8ruN2ZNXUlXZOsA7d7YU-_9-6tuXCz-6ckpibqkXRcpBTG9K7CavAGt2lvPtzDMsckemUNEg1Ic9umSbMwYAjJLLC8zcvUDAERhPHFJnYvvohpCi5QZtSlO9RogRD_FHSBk4.&durs=Cj8avf&crrelr=&fpa=601&pcm=3&vc=12&said=f21c98d0-298f-4072-9ddd-283ddbf6d334&ict=WiFi&auct=1&us_privacy=1YNY&im=1&mc=779627c9-ce7a-47ff-86ff-a528fbacf04e&ev=-MnMmWvA4mOkaPiSxFEboFQpBYxbVu-IhY4IW3Vw5R4.&rsv=0.000641572002978372&abr=9b094bea-8d7c-4e1c-9000-77a7e31a075b&tail=10.79
    https://choices.trustarc.com/cap?aid=tradedesk01&pid=tradedesk01&cid=qj5hz22_5d11yuc_ny02oo6q&w=320&h=50&c=dcb30.04

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2